Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Revolution Medicines, Inc.(RVMD) | 0 | 3,233,490 | +3,233,490 | $0 | $92.74M | 56.72% | +$92.74M |
| Verve Therapeutics, Inc. | 2,008,809 | 2,008,809 | 0 | $26.64M | $28.00M | 17.13% | +$1.37M |
| Erasca, Inc.(ERAS) | 11,055,554 | 11,055,554 | 0 | $21.78M | $23.55M | 14.40% | +$1.77M |
| Denali Therapeutics Inc.(DNLI) | 693,749 | 381,249 | -312,500 | $14.31M | $8.18M | 5.00% | -$6.13M |
| Gossamer Bio, Inc.(GOSS) | 8,055,916 | 8,055,916 | 0 | $6.71M | $7.35M | 4.50% | +$642.1K |
| Unity Biotechnology, Inc. | 1,004,817 | 1,004,817 | 0 | $2.41M | $1.94M | 1.19% | -$472.3K |
| Singular Genomics Systems, Inc. | 3,798,926 | 3,798,926 | 0 | $1.45M | $1.75M | 1.07% | +$300.5K |
| EQRX, INC.COM | 36,335,375 | 0 | -36,335,375 | $80.66M | $0 | — | -$80.66M |